GSK invests $139M to boost lupus drug production
BioPharma Dive: Biotech and Pharma news | May 04, 2017
GlaxoSmithKline will invest $139 million in its Rockville, Maryland manufacturing site, boosting production capacity for its lupus drug Benlysta (belimumab) in response to growing demand.